GB Patent

GB9422571D0 — Haemorrihoidal compositions and method of use

Assigned to Pfizer Consumer Healthcare · Expires 1995-01-04 · 31y expired

What this patent protects

Patent listed against naftifine-hydrochloride.

Drugs covered by this patent

naftifine-hydrochloride (NAFTIFINE HYDROCHLORIDE)

Patent Metadata

Patent number: GB9422571D0
Jurisdiction: GB
Classification: —
Expires: 1995-01-04
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Consumer Healthcare
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.